• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物所致帕金森综合征的临床特征。

Clinical characteristics of neuroleptic-induced parkinsonism.

作者信息

Hassin-Baer S, Sirota P, Korczyn A D, Treves T A, Epstein B, Shabtai H, Martin T, Litvinjuk Y, Giladi N

机构信息

Department of Neurology, Tel-Aviv Medical Center, Israel.

出版信息

J Neural Transm (Vienna). 2001;108(11):1299-308. doi: 10.1007/s007020100006.

DOI:10.1007/s007020100006
PMID:11768628
Abstract

In order to characterize the clinical spectrum of neuroleptic-induced parkinsonism (NIP), we studied a population of consecutive psychiatric in-patients treated with neuroleptics for at least two weeks, who were diagnosed by their psychiatrist as having parkinsonism. Parkinsonism was confirmed by a movement disorders specialist who performed neurological assessment including the motor examination and the activities of daily living (ADL) sections of the Unified Parkinson's Disease Rating Scale (UPDRS), and the Hoehn and Yahr (H&Y) staging. Seventy-five patients (54 males), aged 46 +/- 13 years (range 21 to 73 years) were included in the analysis. The mean duration of neuroleptic therapy was 15 +/- 12 years, while 61% were treated for more than 10 years. Most of the patients (n = 66, 88%) were scored as H&Y stage 2.5 or less. Rest tremor was present in 44% of the patients, and usually persisted in action. Forty-one patients (61%) had symmetrical involvement. Parkinsonian signs were significantly more common and pronounced in the upper in comparison with the lower limbs (p = 0.0001). Gait disturbances were mild and freezing of gait was very rare (n = 2). Neither age nor duration of therapy or their interaction affected the total motor score or any of the motor sub-scores. In conclusion, NIP differs from PD for more bilateral involvement with relative symmetry, and by affecting upper limbs more often than the lower ones. NIP tends to be associated with the triad of bradykinesia, tremor and rigidity while PD tends to involve gait and posture more often. NIP develops unrelated to duration of neuroleptic treatment or age of the patient, suggesting an individual predisposition to blockage of the dopaminergic receptors.

摘要

为了描述抗精神病药物所致帕金森综合征(NIP)的临床谱,我们研究了一组连续的接受抗精神病药物治疗至少两周的精神科住院患者,这些患者被精神科医生诊断为患有帕金森综合征。帕金森综合征由一名运动障碍专家确诊,该专家进行了神经学评估,包括统一帕金森病评定量表(UPDRS)的运动检查和日常生活活动(ADL)部分,以及霍恩和雅尔(H&Y)分期。分析纳入了75例患者(54例男性),年龄为46±13岁(范围21至73岁)。抗精神病药物治疗的平均时长为15±12年,其中61%的患者接受治疗超过10年。大多数患者(n = 66,88%)的H&Y分期为2.5期或更低。44%的患者存在静止性震颤,且通常在动作时持续存在。41例患者(61%)双侧受累。与下肢相比,帕金森体征在上肢明显更常见且更明显(p = 0.0001)。步态障碍较轻,步态冻结非常罕见(n = 2)。年龄、治疗时长及其相互作用均未影响总运动评分或任何运动子评分。总之,NIP与帕金森病(PD)不同,其双侧受累更为常见且相对对称,上肢受累比下肢更频繁。NIP往往与运动迟缓、震颤和强直三联征相关,而PD往往更常累及步态和姿势。NIP的发生与抗精神病药物治疗时长或患者年龄无关,提示个体对多巴胺能受体阻滞存在易感性。

相似文献

1
Clinical characteristics of neuroleptic-induced parkinsonism.抗精神病药物所致帕金森综合征的临床特征。
J Neural Transm (Vienna). 2001;108(11):1299-308. doi: 10.1007/s007020100006.
2
Psychiatric Patients on Neuroleptics: Evaluation of Parkinsonism and Quantified Assessment of Gait.服用抗精神病药物的精神科患者:帕金森症评估与步态定量分析
Clin Neuropharmacol. 2020 Jan/Feb;43(1):1-6. doi: 10.1097/WNF.0000000000000371.
3
Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.抗精神病药物所致帕金森综合征与帕金森病:鉴别诊断与治疗
J Clin Psychiatry. 1983 Jan;44(1):13-6.
4
Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.多系统萎缩中的帕金森综合征:与帕金森病相比的自然史、严重程度(统一帕金森病评定量表第三部分)及残疾评估
Mov Disord. 2002 Jul;17(4):701-9. doi: 10.1002/mds.10171.
5
The clinically important difference on the unified Parkinson's disease rating scale.统一帕金森病评定量表上具有临床意义的差异。
Arch Neurol. 2010 Jan;67(1):64-70. doi: 10.1001/archneurol.2009.295.
6
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.帕金森病的运动和非运动特征可预测持续性药物诱导的帕金森病。
Parkinsonism Relat Disord. 2014 Jul;20(7):738-42. doi: 10.1016/j.parkreldis.2014.03.024. Epub 2014 Apr 1.
7
Comparison of two motor subtype classifications in de novo Parkinson's disease.两种新发帕金森病运动亚型分类的比较。
Parkinsonism Relat Disord. 2018 Sep;54:74-78. doi: 10.1016/j.parkreldis.2018.04.021. Epub 2018 Apr 18.
8
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.在司来吉兰和α-生育酚的一项临床试验中,左旋多巴作为帕金森病进展终点的必要性。帕金森研究小组。
Mov Disord. 1997 Mar;12(2):183-9. doi: 10.1002/mds.870120208.
9
Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.帕金森病、进行性核上性麻痹、多系统萎缩及抗精神病药所致帕金森综合征中的失用症。
Brain. 1997 Jan;120 ( Pt 1):75-90. doi: 10.1093/brain/120.1.75.
10
Clinical correlates of action tremor in Parkinson disease.帕金森病动作性震颤的临床关联
Arch Neurol. 2001 Oct;58(10):1630-4. doi: 10.1001/archneur.58.10.1630.

引用本文的文献

1
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report.氟奋乃静诱导的神经毒性伴急性短暂帕金森病和永久性记忆丧失:病例报告的启示。
Int J Mol Sci. 2023 Feb 3;24(3):2968. doi: 10.3390/ijms24032968.
2
Parkinson disease primer, part 1: diagnosis.帕金森病入门,第 1 部分:诊断。
Can Fam Physician. 2023 Jan;69(1):20-24. doi: 10.46747/cfp.690120.
3
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.药物性帕金森综合征(DIP)管理的最新观点:来自临床的见解
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
4
Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism.步态异常和非运动症状预示着疑似药物性帕金森综合征患者多巴胺能成像异常。
NPJ Parkinsons Dis. 2022 Apr 28;8(1):53. doi: 10.1038/s41531-022-00309-8.
5
Novel case of Parkinson's disease and schizophrenia: challenges in the management.帕金森病和精神分裂症的新病例:管理中的挑战。
BMJ Case Rep. 2021 Jul 29;14(7):e244028. doi: 10.1136/bcr-2021-244028.
6
Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review.老年患者抗精神病药物所致帕金森综合征的识别与管理:一项叙述性综述
Medicines (Basel). 2021 May 26;8(6):24. doi: 10.3390/medicines8060024.
7
Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.基于功能神经影像学诊断的抗精神病药物所致帕金森病的症状特征
Intern Med. 2020;59(4):485-490. doi: 10.2169/internalmedicine.2553-18. Epub 2020 Feb 15.
8
The nature of bradykinesia in schizophrenia treated with antipsychotics.抗精神病药物治疗的精神分裂症患者运动迟缓的本质。
Psychiatry Res. 2019 Mar;273:537-543. doi: 10.1016/j.psychres.2019.01.058. Epub 2019 Jan 15.
9
Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism.嗅觉障碍预示着疑似药物性帕金森综合征潜在的多巴胺能缺陷。
Mov Disord Clin Pract. 2016 Nov 28;4(4):603-606. doi: 10.1002/mdc3.12458. eCollection 2017 Jul-Aug.
10
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.抗精神病药物相关运动障碍:药物性帕金森综合征与迟发性运动障碍——病理生理学和临床管理的关键差异
Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.